Nan Fung Trinity’s Bristol-Myers Squibb BMY Stock Holding History

Nan Fung Trinity’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-115,893	Closed	-$8.46M	–	25
2022 Q1	$8.46M	Sell	115,893 -219,200	-65%	-$14.7M	1.62%	18
2021 Q4	$20.9M	Buy	335,093 +36,000	+12%	+$2.11M	4.54%	12
2021 Q3	$17.7M	Hold	299,093	–	–	4.21%	10
2021 Q2	$20M	Buy	299,093 +100,508	+51%	+$6.55M	4.19%	11
2021 Q1	$12.5M	Buy	198,585 +49,400	+33%	+$3.07M	2.76%	17
2020 Q4	$9.25M	Buy	149,185 +80,685	+118%	+$4.96M	1.64%	20
2020 Q3	$4.13M	Hold	68,500	–	–	0.83%	27
2020 Q2	$4.03M	Hold	68,500	–	–	0.89%	25
2020 Q1	$3.82M	Sell	68,500 -68,500	-50%	-$4.19M	1.13%	22
2019 Q4	$8.79M	Buy	+137,000	New	+$7.85M	1.69%	16

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nan Fung Trinity's BMY Position: Q2 2022 in Review

Nan Fung Trinity sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 115,893 shares — an estimated $8.46M sold.

Nan Fung Trinity first reported a position in BMY in Q4 2019 and held it in 10 quarters. The position peaked at $20.9M in Q4 2021. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

Nan Fung Trinity reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
Nan Fung Trinity sold 115,893 Bristol-Myers Squibb shares in Q2 2022, an estimated $8.46M.
Nan Fung Trinity first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 10 quarters.
Nan Fung Trinity's Bristol-Myers Squibb position peaked at $20.9M in Q4 2021.
2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Nan Fung Trinity's 13F filing for Q2 2022, filed 9 Aug 2022.